Works matching IS 23745347 AND DT 2024 AND VI 25 AND IP 13
Results: 16
The Top News From ESMO 2024: A Variety of Data Inform Solid Tumor Landscapes.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 54
- By:
- Publication type:
- Article
Nuances of HER2 Expression Underscore Need for More Precise Testing in Breast Cancer.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 50
- By:
- Publication type:
- Article
Rural Health Care Is Falling Behind Nationally, and Action Is Needed Now, AMA President Says.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 48
- By:
- Publication type:
- Article
A Multipronged Approach Can Address Disparities in Cancer Care for Patients in Rural Communities.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 47
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 40
- By:
- Publication type:
- Article
TakeAim Lymphoma Tests Proof of Concept for Dual IRAK4/FLT3 Blockade in B-Cell Malignancy Treatment.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 34
- By:
- Publication type:
- Article
Effectively Targeting c-Met in Colorectal Cancer Is Becoming a Reality With Novel Approaches.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 28
- By:
- Publication type:
- Article
ctDNA Generates Momentum in Adjuvant Stage II/III Colon Cancer Setting.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 25
- By:
- Publication type:
- Article
Immunotherapy Combinations Dominate Frontline Discussions in Advanced RCC.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 16
- By:
- Publication type:
- Article
Vorasidenib Breaks Through as the First Systemic Therapy for Select Patients With Glioma.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 10
- By:
- Publication type:
- Article
Axatilimab Receives Green Light for Chronic Graft-vs-Host Disease.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 8
- Publication type:
- Article
Amivantamab Plus Lazertinib Earns Indication for First-Line EGFR+ Advanced NSCLC.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 8
- Publication type:
- Article
Denileukin Diftitox Snags Approval for R/R Cutaneous T-Cell Lymphoma.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 8
- Publication type:
- Article
Perioperative Durvalumab Plus Chemotherapy Receives Go-Ahead in Resectable NSCLC.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 8
- Publication type:
- Article
The Escalating Need for Robust Decision Support in Oncology: Ovarian Cancer as an Example.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 6
- By:
- Publication type:
- Article
Positive and Negative Data Provide Needed Elucidation in Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 13, p. 4
- By:
- Publication type:
- Article